Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology guidelines

Martha B. Pitman, Barbara A. Centeno, Syed Z. Ali, Muriel Genevay, Ed Stelow, Mari Mino-Kenudson, Carlos Fernandez-Del Castillo, C. Max Schmidt, William Brugge, Lester Layfield

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

The Papanicolaou Society of Cytopathology has developed a set of guidelines for pancreatobiliary cytology including indications for endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) biopsy, techniques of EUS-FNA, terminology and nomenclature of pancreatobiliary disease, ancillary testing, and postbiopsy treatment and management. All documents are based on the expertise of the authors, a review of the literature, discussions of the draft document at several national and international meetings over an 18-month period and synthesis of online comments of the draft document on the Papanicolaou Society of Cytopathology web site (www.papsociety.org). This document selectively presents the results of these discussions and focuses on a proposed standardized terminology scheme for pancreatobiliary specimens that correlate cytological diagnosis with biological behavior and increasingly conservative patient management of surveillance only. The proposed terminology scheme recommends a six-tiered system: Nondiagnostic, Negative, Atypical, Neoplastic (benign or other), Suspicious and Positive. Unique to this scheme is the "Neoplastic" category separated into "benign" (serous cystadenoma), or "Other" (premalignant mucinous cysts, neuroendocrine tumors, and solid-pseudopapillary neoplasms). The positive or malignant category is reserved for high-grade, aggressive malignancies including ductal adenocarcinoma, acinar cell carcinoma, poorly differentiated neuroendocrine carcinomas, pancreatoblastoma, lymphoma, and metastases. Interpretation categories do not have to be used. Some pathology laboratory information systems require an interpretation category, which places the cytological diagnosis into a general category. This proposed scheme provides terminology that standardizes the category of the various diseases of the pancreas, some of which are difficult to diagnose specifically by cytology. In addition, this terminology scheme attempts to provide maximum flexibility for patient management, which has become increasingly conservative for some neoplasms.

Original languageEnglish (US)
Pages (from-to)338-350
Number of pages13
JournalDiagnostic Cytopathology
Volume42
Issue number4
DOIs
StatePublished - Apr 2014

Fingerprint

Terminology
Cell Biology
Guidelines
Fine Needle Biopsy
Clinical Laboratory Information Systems
Serous Cystadenoma
Acinar Cell Carcinoma
Endoscopic Ultrasound-Guided Fine Needle Aspiration
Neuroendocrine Carcinoma
Neoplasms
Neuroendocrine Tumors
Cysts
Pancreas
Lymphoma
Adenocarcinoma
Pathology
Neoplasm Metastasis

Keywords

  • guidelines
  • nomenclature
  • pancreas
  • PSC
  • terminology

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Pitman, M. B., Centeno, B. A., Ali, S. Z., Genevay, M., Stelow, E., Mino-Kenudson, M., ... Layfield, L. (2014). Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology guidelines. Diagnostic Cytopathology, 42(4), 338-350. https://doi.org/10.1002/dc.23092

Standardized terminology and nomenclature for pancreatobiliary cytology : The Papanicolaou Society of Cytopathology guidelines. / Pitman, Martha B.; Centeno, Barbara A.; Ali, Syed Z.; Genevay, Muriel; Stelow, Ed; Mino-Kenudson, Mari; Fernandez-Del Castillo, Carlos; Max Schmidt, C.; Brugge, William; Layfield, Lester.

In: Diagnostic Cytopathology, Vol. 42, No. 4, 04.2014, p. 338-350.

Research output: Contribution to journalArticle

Pitman, MB, Centeno, BA, Ali, SZ, Genevay, M, Stelow, E, Mino-Kenudson, M, Fernandez-Del Castillo, C, Max Schmidt, C, Brugge, W & Layfield, L 2014, 'Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology guidelines', Diagnostic Cytopathology, vol. 42, no. 4, pp. 338-350. https://doi.org/10.1002/dc.23092
Pitman, Martha B. ; Centeno, Barbara A. ; Ali, Syed Z. ; Genevay, Muriel ; Stelow, Ed ; Mino-Kenudson, Mari ; Fernandez-Del Castillo, Carlos ; Max Schmidt, C. ; Brugge, William ; Layfield, Lester. / Standardized terminology and nomenclature for pancreatobiliary cytology : The Papanicolaou Society of Cytopathology guidelines. In: Diagnostic Cytopathology. 2014 ; Vol. 42, No. 4. pp. 338-350.
@article{e1cba57c28fd4524b64bacf4f47fc5b8,
title = "Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology guidelines",
abstract = "The Papanicolaou Society of Cytopathology has developed a set of guidelines for pancreatobiliary cytology including indications for endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) biopsy, techniques of EUS-FNA, terminology and nomenclature of pancreatobiliary disease, ancillary testing, and postbiopsy treatment and management. All documents are based on the expertise of the authors, a review of the literature, discussions of the draft document at several national and international meetings over an 18-month period and synthesis of online comments of the draft document on the Papanicolaou Society of Cytopathology web site (www.papsociety.org). This document selectively presents the results of these discussions and focuses on a proposed standardized terminology scheme for pancreatobiliary specimens that correlate cytological diagnosis with biological behavior and increasingly conservative patient management of surveillance only. The proposed terminology scheme recommends a six-tiered system: Nondiagnostic, Negative, Atypical, Neoplastic (benign or other), Suspicious and Positive. Unique to this scheme is the {"}Neoplastic{"} category separated into {"}benign{"} (serous cystadenoma), or {"}Other{"} (premalignant mucinous cysts, neuroendocrine tumors, and solid-pseudopapillary neoplasms). The positive or malignant category is reserved for high-grade, aggressive malignancies including ductal adenocarcinoma, acinar cell carcinoma, poorly differentiated neuroendocrine carcinomas, pancreatoblastoma, lymphoma, and metastases. Interpretation categories do not have to be used. Some pathology laboratory information systems require an interpretation category, which places the cytological diagnosis into a general category. This proposed scheme provides terminology that standardizes the category of the various diseases of the pancreas, some of which are difficult to diagnose specifically by cytology. In addition, this terminology scheme attempts to provide maximum flexibility for patient management, which has become increasingly conservative for some neoplasms.",
keywords = "guidelines, nomenclature, pancreas, PSC, terminology",
author = "Pitman, {Martha B.} and Centeno, {Barbara A.} and Ali, {Syed Z.} and Muriel Genevay and Ed Stelow and Mari Mino-Kenudson and {Fernandez-Del Castillo}, Carlos and {Max Schmidt}, C. and William Brugge and Lester Layfield",
year = "2014",
month = "4",
doi = "10.1002/dc.23092",
language = "English (US)",
volume = "42",
pages = "338--350",
journal = "Diagnostic Cytopathology",
issn = "8755-1039",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Standardized terminology and nomenclature for pancreatobiliary cytology

T2 - The Papanicolaou Society of Cytopathology guidelines

AU - Pitman, Martha B.

AU - Centeno, Barbara A.

AU - Ali, Syed Z.

AU - Genevay, Muriel

AU - Stelow, Ed

AU - Mino-Kenudson, Mari

AU - Fernandez-Del Castillo, Carlos

AU - Max Schmidt, C.

AU - Brugge, William

AU - Layfield, Lester

PY - 2014/4

Y1 - 2014/4

N2 - The Papanicolaou Society of Cytopathology has developed a set of guidelines for pancreatobiliary cytology including indications for endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) biopsy, techniques of EUS-FNA, terminology and nomenclature of pancreatobiliary disease, ancillary testing, and postbiopsy treatment and management. All documents are based on the expertise of the authors, a review of the literature, discussions of the draft document at several national and international meetings over an 18-month period and synthesis of online comments of the draft document on the Papanicolaou Society of Cytopathology web site (www.papsociety.org). This document selectively presents the results of these discussions and focuses on a proposed standardized terminology scheme for pancreatobiliary specimens that correlate cytological diagnosis with biological behavior and increasingly conservative patient management of surveillance only. The proposed terminology scheme recommends a six-tiered system: Nondiagnostic, Negative, Atypical, Neoplastic (benign or other), Suspicious and Positive. Unique to this scheme is the "Neoplastic" category separated into "benign" (serous cystadenoma), or "Other" (premalignant mucinous cysts, neuroendocrine tumors, and solid-pseudopapillary neoplasms). The positive or malignant category is reserved for high-grade, aggressive malignancies including ductal adenocarcinoma, acinar cell carcinoma, poorly differentiated neuroendocrine carcinomas, pancreatoblastoma, lymphoma, and metastases. Interpretation categories do not have to be used. Some pathology laboratory information systems require an interpretation category, which places the cytological diagnosis into a general category. This proposed scheme provides terminology that standardizes the category of the various diseases of the pancreas, some of which are difficult to diagnose specifically by cytology. In addition, this terminology scheme attempts to provide maximum flexibility for patient management, which has become increasingly conservative for some neoplasms.

AB - The Papanicolaou Society of Cytopathology has developed a set of guidelines for pancreatobiliary cytology including indications for endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) biopsy, techniques of EUS-FNA, terminology and nomenclature of pancreatobiliary disease, ancillary testing, and postbiopsy treatment and management. All documents are based on the expertise of the authors, a review of the literature, discussions of the draft document at several national and international meetings over an 18-month period and synthesis of online comments of the draft document on the Papanicolaou Society of Cytopathology web site (www.papsociety.org). This document selectively presents the results of these discussions and focuses on a proposed standardized terminology scheme for pancreatobiliary specimens that correlate cytological diagnosis with biological behavior and increasingly conservative patient management of surveillance only. The proposed terminology scheme recommends a six-tiered system: Nondiagnostic, Negative, Atypical, Neoplastic (benign or other), Suspicious and Positive. Unique to this scheme is the "Neoplastic" category separated into "benign" (serous cystadenoma), or "Other" (premalignant mucinous cysts, neuroendocrine tumors, and solid-pseudopapillary neoplasms). The positive or malignant category is reserved for high-grade, aggressive malignancies including ductal adenocarcinoma, acinar cell carcinoma, poorly differentiated neuroendocrine carcinomas, pancreatoblastoma, lymphoma, and metastases. Interpretation categories do not have to be used. Some pathology laboratory information systems require an interpretation category, which places the cytological diagnosis into a general category. This proposed scheme provides terminology that standardizes the category of the various diseases of the pancreas, some of which are difficult to diagnose specifically by cytology. In addition, this terminology scheme attempts to provide maximum flexibility for patient management, which has become increasingly conservative for some neoplasms.

KW - guidelines

KW - nomenclature

KW - pancreas

KW - PSC

KW - terminology

UR - http://www.scopus.com/inward/record.url?scp=84896397072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896397072&partnerID=8YFLogxK

U2 - 10.1002/dc.23092

DO - 10.1002/dc.23092

M3 - Article

C2 - 24554455

AN - SCOPUS:84896397072

VL - 42

SP - 338

EP - 350

JO - Diagnostic Cytopathology

JF - Diagnostic Cytopathology

SN - 8755-1039

IS - 4

ER -